MicroRNA-494 inhibits the growth and angiogenesis-regulating potential of mesenchymal stem cells.

Shiwen Chen,Guangfeng Zhao,Huishuang Miao,Ruijing Tang,Yuxian Song,Yali Hu,Zhiqun Wang,Yayi Hou
DOI: https://doi.org/10.1016/j.febslet.2015.01.038
2015-01-01
FEBS Letters
Abstract:Mesenchymal stem cells (MSCs) play an important role in the pathology of preeclampsia (PE). Our previous microarray analysis found that microRNA-494 (miR-494) is highly expressed in decidua-derived MSCs (dMSCs) from PE. We hypothesized that aberrant expression of miR-494 in dMSCs is involved in PE development. In the present study, we found that miR-494 arrests G1/S transition in dMSCs by targeting CDK6 and CCND1. We also found that supernatant from miR-494-overexpressing dMSCs reduces HTR-8/SVneo migration and impairs HUVEC capillary formation by suppressing VEGF. Taken together, we report an unrecognized mechanism of miR-494 affecting dMSC proliferation and function in the pathology of PE.
What problem does this paper attempt to address?